Fritsche-Guenther R - Search Results

1

Effects of RAF inhibitors on PI3K/AKT signalling depend on mutational status of the RAS/RAF signalling axis.

Fritsche-Guenther R, Witzel F, Kempa S, Brummer T, Sers C, Blüthgen N. Fritsche-Guenther R, et al. Oncotarget. 2016 Feb 16;7(7):7960-9. doi: 10.18632/oncotarget.6959. Oncotarget. 2016. PMID: 26799289 Free PMC article.

2

De novo expression of EphA2 in osteosarcoma modulates activation of the mitogenic signalling pathway.

Fritsche-Guenther R, Noske A, Ungethüm U, Kuban RJ, Schlag PM, Tunn PU, Karle J, Krenn V, Dietel M, Sers C. Fritsche-Guenther R, et al. Histopathology. 2010 Dec;57(6):836-50. doi: 10.1111/j.1365-2559.2010.03713.x. Histopathology. 2010. PMID: 21166698

3

Therapeutic potential of CAMPATH-1H in skeletal tumours.

Fritsche-Guenther R, Gruetzkau A, Noske A, Melcher I, Schaser KD, Schlag PM, Kasper HU, Krenn V, Sers C. Fritsche-Guenther R, et al. Histopathology. 2010 Dec;57(6):851-61. doi: 10.1111/j.1365-2559.2010.03722.x. Histopathology. 2010. PMID: 21166699

4

Strong negative feedback from Erk to Raf confers robustness to MAPK signalling.

Fritsche-Guenther R, Witzel F, Sieber A, Herr R, Schmidt N, Braun S, Brummer T, Sers C, Blüthgen N. Fritsche-Guenther R, et al. Mol Syst Biol. 2011 May 24;7:489. doi: 10.1038/msb.2011.27. Mol Syst Biol. 2011. PMID: 21613978 Free PMC article.

5

Network quantification of EGFR signaling unveils potential for targeted combination therapy.

Klinger B, Sieber A, Fritsche-Guenther R, Witzel F, Berry L, Schumacher D, Yan Y, Durek P, Merchant M, Schäfer R, Sers C, Blüthgen N. Klinger B, et al. Mol Syst Biol. 2013;9:673. doi: 10.1038/msb.2013.29. Mol Syst Biol. 2013. PMID: 23752269 Free PMC article.

6

Analysis of impedance-based cellular growth assays.

Witzel F, Fritsche-Guenther R, Lehmann N, Sieber A, Blüthgen N. Witzel F, et al. Bioinformatics. 2015 Aug 15;31(16):2705-12. doi: 10.1093/bioinformatics/btv216. Epub 2015 Apr 21. Bioinformatics. 2015. PMID: 25900918

7

An immediate-late gene expression module decodes ERK signal duration.

Uhlitz F, Sieber A, Wyler E, Fritsche-Guenther R, Meisig J, Landthaler M, Klinger B, Blüthgen N. Uhlitz F, et al. Mol Syst Biol. 2017 May 3;13(5):928. doi: 10.15252/msb.20177554. Mol Syst Biol. 2017. PMID: 28468958 Free PMC article.

8

Alterations of mTOR signaling impact metabolic stress resistance in colorectal carcinomas with BRAF and KRAS mutations.

Fritsche-Guenther R, Zasada C, Mastrobuoni G, Royla N, Rainer R, Roßner F, Pietzke M, Klipp E, Sers C, Kempa S. Fritsche-Guenther R, et al. Sci Rep. 2018 Jun 15;8(1):9204. doi: 10.1038/s41598-018-27394-1. Sci Rep. 2018. PMID: 29907857 Free PMC article.

9

Optimized Workflow for On-Line Derivatization for Targeted Metabolomics Approach by Gas Chromatography-Mass Spectrometry.

Fritsche-Guenther R, Gloaguen Y, Bauer A, Opialla T, Kempa S, Fleming CA, Redmond HP, Kirwan JA. Fritsche-Guenther R, et al. Metabolites. 2021 Dec 18;11(12):888. doi: 10.3390/metabo11120888. Metabolites. 2021. PMID: 34940646 Free PMC article.

10

Quantifying the impact of gut microbiota on inflammation and hypertensive organ damage.

Avery EG, Bartolomaeus H, Rauch A, Chen CY, N'Diaye G, Löber U, Bartolomaeus TUP, Fritsche-Guenther R, Rodrigues AF, Yarritu A, Zhong C, Fei L, Tsvetkov D, Todiras M, Park JK, Markó L, Maifeld A, Patzak A, Bader M, Kempa S, Kirwan JA, Forslund SK, Müller DN, Wilck N. Avery EG, et al. Cardiovasc Res. 2023 Jun 13;119(6):1441-1452. doi: 10.1093/cvr/cvac121. Cardiovasc Res. 2023. PMID: 35904261 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters